Received Mar 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
Headache; Shivers; Fever; severely tired; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine with an associated reaction of pyrexia (got a fever, headache, shivers and severely tired approximately 8 hours and symptoms lasted 24 hours). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, 8 hrs after receiving Shingles vaccine, the patient experienced headache (Verbatim: Headache), shivers (Verbatim: Shivers), fever (Verbatim: Fever) and tiredness (Verbatim: severely tired). Rechallenge with Shingles vaccine was positive. The outcome of the headache, shivers, fever and tiredness were resolved (duration 24 hrs). It was unknown if the reporter considered the headache, shivers, fever and tiredness to be related to Shingles vaccine. It was unknown if the company considered the headache, shivers, fever and tiredness to be related to Shingles vaccine. Linked case(s) involving the same patient: US2026AMR025375 Additional Information: GSK Receipt Date: 20-FEB-2026 This case was reported by a patient via interactive digital media. The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: US-GSK-US2026AMR025375: